Association of pulmonary and cardiac manifestations in patients with primary antiphospholipid syndrome: A review of the Serbian national cohort study

Milica Kontic (Belgrade, Republic of Serbia), Milica Kontic, Ljudmila Stojanovich, Aleksandra Djokovic

Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Session: Acute and chronic lung diseases: good clinical practice
Session type: Thematic Poster Session
Number: 3684
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Milica Kontic (Belgrade, Republic of Serbia), Milica Kontic, Ljudmila Stojanovich, Aleksandra Djokovic. Association of pulmonary and cardiac manifestations in patients with primary antiphospholipid syndrome: A review of the Serbian national cohort study. Eur Respir J 2015; 46: Suppl. 59, 3684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015



Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019
Year: 2019



Idiopathic Pulmonary Fibrosis based on disease behavior: Workshop summary of a Japanese multicenter study
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019

Pulmonary manifestations in patients with IgG4-related disease at a tertiary care institute
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015


European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency
Source: Eur Respir J, 50 (5) 1700610; 10.1183/13993003.00610-2017
Year: 2017



European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency
Source: Guideline 2017
Year: 2017


Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Pulmonary veno-occlusive disease (PVOD) induced by chemotherapy: Experience from the French PH network and literature review
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
Source: Eur Respir J 2012; 39: 945-955
Year: 2012



Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort
Source: International Congress 2016 – The best is yet to come in terms of lung function
Year: 2016



Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Cardiac sarcoidosis is more frequent in males – Large cohort (n=1375) sarcoid patients analysis – 5 years experience in the National TB & Lung Diseases Research Institute in Warsaw, Poland
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Predictors of mortality in otherwise healthy patients with pulmonary tuberculosis: A retrospective cohort study
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry
Source: Eur Respir J 2001; 18: Suppl. 33, 510s
Year: 2001

Subcutaneous sarcoidosis: A clinical analysis of nine patients
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015